Wird geladen...
Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
AIMS: Sacubitril/valsartan (SV) reduced heart failure hospitalization and cardiovascular mortality compared with enalapril in the Prospective Comparison of ARNI with ACE‐I to Determine Impact on Global Mortality and Morbidity in Heart Failure trial. However, this trial excluded patients with end sta...
Gespeichert in:
| Veröffentlicht in: | ESC Heart Fail |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261577/ https://ncbi.nlm.nih.gov/pubmed/32153122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12659 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|